Covariate | n | OS | PFS | |||||||||
Estimated 5-year survival (%) | Univariate p-value | RR | 95% CI | Multivariate p-value | Estimated 5-year survival (%) | Univariate p-value | RR | 95% CI | Multivariate p-value | |||
Age | <50 years | 13 | 61.4 | 0.904 | 42.1 | 0.982 | ||||||
≥50 years | 13 | 40.0 | 34.6 | |||||||||
Stage | IB | 20 | 53.8 | 0.188 | 35.5 | 0.597 | ||||||
IIA+IIB | 6 | 40.0 | 40.0 | |||||||||
NAC | Received | 15 | 51.3 | 0.510 | 31.4 | 0.717 | ||||||
Not received | 11 | (60.0)* | (72.7)* | |||||||||
Adjuvant therapy | Concurrent chemoradiotherapy | 9 | (57.1)* | 0.543 | (63.5)* | 0.424 | ||||||
Radiotherapy alone | 3 | 100.0 | 100.0 | |||||||||
Chemotherapy alone | 14 | 46.9 | 25.6 | |||||||||
Lymph node metastasis | Negative | 13 | 80.0 | 0.023 | 7.21 | 0.89 - 58.46 | 0.064 | 65.6 | 0.0027 | 6.47 | 1.33 - 31.43 | 0.021 |
Positive | 13 | 30.0 | 17.1 | |||||||||
Parametrial invasion | Negative | 19 | 54.1 | 0.158 | 60.4 | 0.0158 | 2.68 | 0.83 - 8.66 | 0.099 | |||
Positive | 7 | 33.3 | 0 | |||||||||
Surgical margin | Negative | 25 | 52.2 | 0.207 | 38.4 | 0.097 | ||||||
Positive | 1 | 0 | 0 | |||||||||
Maximum tumor diameter | <4 cm | 9 | 60.0 | 0.259 | 44.4 | 0.291 | ||||||
≥4 cm | 17 | 46.2 | 30.9 | |||||||||
LVSI | Negative | 13 | 75.0 | 0.035 | 4.41 | 0.89 - 21.98 | 0.070 | 37.7 | 0.126 | |||
Positive | 13 | 25.6 | 36.1 | |||||||||
Deep stromal invasion | Negative | 8 | 83.3 | 0.371 | 65.6 | 0.256 | ||||||
Positive | 18 | 41.9 | 26.0 |